| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.299 | 6.965 | - | 0 | - | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 9.492 | 6.965 | - | 0 | - | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 15.807 | 4.759 | - | 242 | - | 272 | 221 | 289 | 0 | - |
| Gross Profit/Loss - EUR | -6.315 | 2.206 | - | -242 | - | -272 | -221 | -289 | 0 | - |
| Net Profit/Loss - EUR | -6.594 | 2.042 | - | -242 | - | -272 | -221 | -289 | 0 | - |
| Employees | 1 | 1 | - | 1 | - | 1 | 0 | 0 | 0 | - |
Check the financial reports for the company - Alcamedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | - |
| Current Assets | 41.755 | 42.130 | - | 22.451 | - | 21.266 | 20.794 | 19.108 | 19.050 | - |
| Inventories | 5.107 | 11.001 | - | 9.051 | - | 8.707 | 8.514 | 8.541 | 8.515 | - |
| Receivables | 379 | 307 | - | 6.291 | - | 6.052 | 5.918 | 5.957 | 5.939 | - |
| Cash | 36.269 | 30.822 | - | 7.110 | - | 6.507 | 6.362 | 4.611 | 4.597 | - |
| Shareholders Funds | 21.494 | 23.317 | - | 18.514 | - | 17.288 | 16.684 | 16.447 | 16.397 | - |
| Social Capital | 450 | 445 | - | 430 | - | 413 | 404 | 406 | 404 | - |
| Debts | 20.239 | 18.814 | - | 3.915 | - | 3.958 | 4.091 | 2.642 | 2.634 | - |
| Income in Advance | 22 | 22 | - | 21 | - | 21 | 20 | 20 | 20 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Alcamedica Srl